NCT00761137View on ClinicalTrials.gov

Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Sialorrhea Secondary to Parkinson's Disease
Interventions
DRUG

0.3 mg tropicamide

0.3 mg tropicamide in intra-oral thin film

DRUG

1 mg tropicamide

1 mg tropicamide in intra-oral thin film

DRUG

3 mg tropicamide

3 mg tropicamide in intra-oral thin film

DRUG

0 mg tropicamide

0 mg tropicamide (placebo) in intra-oral thin film

Trial Locations (1)

Unknown

FLENI Hospital, Buenos Aires

Sponsors
All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

NeuroHealing Pharmaceuticals Inc.

INDUSTRY

NCT00761137 - Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients | Biotech Hunter | Biotech Hunter